Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
[No title available]

The open microbiology journal

Carkaci D, Nielsen XC, Fuursted K, Skov R, Skovgaard O, Trallero EP, Lienhard R, Åhman J, Matuschek E, Kahlmeter G, Christensen JJ.
PMID: 29151992
Open Microbiol J. 2017 Sep 21;11:160-166. doi: 10.2174/1874285801711010160. eCollection 2017.

OBJECTIVE: In this investigation 120 METHODS: Three susceptibility testing methods were used; disk diffusion according to The European Committee on Antimicrobial Susceptibility Testing (EUCAST) standardized disk diffusion methodology and MIC determination with Etest and broth microdilution (BMD). All testing...

Cite
Carkaci D, Nielsen XC, Fuursted K, et al. . Open Microbiol J. 2017;11:160-166doi: 10.2174/1874285801711010160.
Carkaci, D., Nielsen, X. C., Fuursted, K., Skov, R., Skovgaard, O., Trallero, E. P., Lienhard, R., Åhman, J., Matuschek, E., Kahlmeter, G., & Christensen, J. J. (2017). . The open microbiology journal, 11160-166. https://doi.org/10.2174/1874285801711010160
Carkaci, Derya, et al. "." The open microbiology journal vol. 11 (2017): 160-166. doi: https://doi.org/10.2174/1874285801711010160
Carkaci D, Nielsen XC, Fuursted K, Skov R, Skovgaard O, Trallero EP, Lienhard R, Åhman J, Matuschek E, Kahlmeter G, Christensen JJ. . Open Microbiol J. 2017 Sep 21;11:160-166. doi: 10.2174/1874285801711010160. eCollection 2017. PMID: 29151992; PMCID: PMC5676010.
Copy Download .nbib Format: NLM
Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination.

BMJ open gastroenterology

Erikstrup LT, Aarup M, Hagemann-Madsen R, Dagnaes-Hansen F, Kristensen B, Olsen KE, Fuursted K.
PMID: 26568840
BMJ Open Gastroenterol. 2015 Nov 02;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015.

OBJECTIVE: Clostridium difficile is a major cause of nosocomial infectious diarrhoea. Treatment of C. difficile infection (CDI) depends on disease severity. A combination of vancomycin and metronidazole is often recommended in severe cases. The aim of this study was...

Cite
Erikstrup LT, Aarup M, Hagemann-Madsen R, et al. Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ Open Gastroenterol. 2015;2(1):e000038doi: 10.1136/bmjgast-2015-000038.
Erikstrup, L. T., Aarup, M., Hagemann-Madsen, R., Dagnaes-Hansen, F., Kristensen, B., Olsen, K. E., & Fuursted, K. (2015). Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ open gastroenterology, 2(1), e000038. https://doi.org/10.1136/bmjgast-2015-000038
Erikstrup, Lise Tornvig, et al. "Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination." BMJ open gastroenterology vol. 2,1 (2015): e000038. doi: https://doi.org/10.1136/bmjgast-2015-000038
Erikstrup LT, Aarup M, Hagemann-Madsen R, Dagnaes-Hansen F, Kristensen B, Olsen KE, Fuursted K. Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination. BMJ Open Gastroenterol. 2015 Nov 02;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015. PMID: 26568840; PMCID: PMC4641438.
Copy Download .nbib Format: NLM
[The nose can be the focus of treatment and prophylactic approaches against COVID-19].

Ugeskrift for laeger

Rusan M, Ovesen TOK, Fuursted K, Ovesen T.
PMID: 34596523
Ugeskr Laeger. 2021 Sep 13;183(37).

Infection with SARS-CoV-2 frequently commences in the nasal cavity, yet knowledge about this initial virus-host interaction is sparse. In this review, we update our current understanding of SARS-CoV-2 infection via the nasal epithelium and the associated local immune response....

Cite
Rusan M, Ovesen TOK, Fuursted K, et al. [The nose can be the focus of treatment and prophylactic approaches against COVID-19]. Ugeskr Laeger. 2021;183(37)
Rusan, M., Ovesen, T. O. K., Fuursted, K., & Ovesen, T. (2021). [The nose can be the focus of treatment and prophylactic approaches against COVID-19]. Ugeskrift for laeger, 183(37), .
Rusan, Maria, et al. "[The nose can be the focus of treatment and prophylactic approaches against COVID-19]." Ugeskrift for laeger vol. 183,37 (2021).
Rusan M, Ovesen TOK, Fuursted K, Ovesen T. [The nose can be the focus of treatment and prophylactic approaches against COVID-19]. Ugeskr Laeger. 2021 Sep 13;183(37). Danish. PMID: 34596523.
Copy Download .nbib Format: NLM
A case report describing Candida albicans endophthalmitis demonstrated by 16S/18S microbiome sequencing.

Acta ophthalmologica

Soelberg KK, Datcu R, Jørgensen CAB, Faber C, Wied J, Fuursted K, Justesen US.
PMID: 33426773
Acta Ophthalmol. 2021 Dec;99(8):e1536-e1537. doi: 10.1111/aos.14740. Epub 2021 Jan 10.

No abstract available.

Cite
Soelberg KK, Datcu R, Jørgensen CAB, et al. A case report describing Candida albicans endophthalmitis demonstrated by 16S/18S microbiome sequencing. Acta Ophthalmol. 2021;99(8):e1536-e1537doi: 10.1111/aos.14740.
Soelberg, K. K., Datcu, R., Jørgensen, C. A. B., Faber, C., Wied, J., Fuursted, K., & Justesen, U. S. (2021). A case report describing Candida albicans endophthalmitis demonstrated by 16S/18S microbiome sequencing. Acta ophthalmologica, 99(8), e1536-e1537. https://doi.org/10.1111/aos.14740
Soelberg, Kerstin K, et al. "A case report describing Candida albicans endophthalmitis demonstrated by 16S/18S microbiome sequencing." Acta ophthalmologica vol. 99,8 (2021): e1536-e1537. doi: https://doi.org/10.1111/aos.14740
Soelberg KK, Datcu R, Jørgensen CAB, Faber C, Wied J, Fuursted K, Justesen US. A case report describing Candida albicans endophthalmitis demonstrated by 16S/18S microbiome sequencing. Acta Ophthalmol. 2021 Dec;99(8):e1536-e1537. doi: 10.1111/aos.14740. Epub 2021 Jan 10. PMID: 33426773.
Copy Download .nbib Format: NLM
Probiotics in hidradenitis suppurativa: a potential treatment option?.

Clinical and experimental dermatology

Ring HC, Thorsen J, Fuursted K, Bjarnsholt T, Bay L, Saunte DM, Thomsen SF, Jemec GB.
PMID: 34236727
Clin Exp Dermatol. 2022 Jan;47(1):139-141. doi: 10.1111/ced.14838. Epub 2021 Aug 03.

No abstract available.

Cite
Ring HC, Thorsen J, Fuursted K, et al. Probiotics in hidradenitis suppurativa: a potential treatment option?. Clin Exp Dermatol. 2021;47(1):139-141doi: 10.1111/ced.14838.
Ring, H. C., Thorsen, J., Fuursted, K., Bjarnsholt, T., Bay, L., Saunte, D. M., Thomsen, S. F., & Jemec, G. B. (2022). Probiotics in hidradenitis suppurativa: a potential treatment option?. Clinical and experimental dermatology, 47(1), 139-141. https://doi.org/10.1111/ced.14838
Ring, H C, et al. "Probiotics in hidradenitis suppurativa: a potential treatment option?." Clinical and experimental dermatology vol. 47,1 (2022): 139-141. doi: https://doi.org/10.1111/ced.14838
Ring HC, Thorsen J, Fuursted K, Bjarnsholt T, Bay L, Saunte DM, Thomsen SF, Jemec GB. Probiotics in hidradenitis suppurativa: a potential treatment option?. Clin Exp Dermatol. 2022 Jan;47(1):139-141. doi: 10.1111/ced.14838. Epub 2021 Aug 03. PMID: 34236727.
Copy Download .nbib Format: NLM
Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations.

Clinical & translational immunology

Knuutila A, Dalby T, Barkoff AM, Jørgensen CS, Fuursted K, Mertsola J, Markey K, He Q.
PMID: 32765879
Clin Transl Immunology. 2020 Aug 02;9(8):e1161. doi: 10.1002/cti2.1161. eCollection 2020.

OBJECTIVES: Pertussis toxin (PT) is a component of all acellular pertussis vaccines. PT must be detoxified to be included in acellular vaccines, which results in conformational changes in the functional epitopes of PTs. Therefore, induced epitope-specific antibodies to PT...

Cite
Knuutila A, Dalby T, Barkoff AM, et al. Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations. Clin Transl Immunology. 2020;9(8):e1161doi: 10.1002/cti2.1161.
Knuutila, A., Dalby, T., Barkoff, A. M., Jørgensen, C. S., Fuursted, K., Mertsola, J., Markey, K., & He, Q. (2020). Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations. Clinical & translational immunology, 9(8), e1161. https://doi.org/10.1002/cti2.1161
Knuutila, Aapo, et al. "Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations." Clinical & translational immunology vol. 9,8 (2020): e1161. doi: https://doi.org/10.1002/cti2.1161
Knuutila A, Dalby T, Barkoff AM, Jørgensen CS, Fuursted K, Mertsola J, Markey K, He Q. Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations. Clin Transl Immunology. 2020 Aug 02;9(8):e1161. doi: 10.1002/cti2.1161. eCollection 2020. PMID: 32765879; PMCID: PMC7396262.
Copy Download .nbib Format: NLM
The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination.

Heliyon

Slotved HC, Dalby T, Harboe ZB, Valentiner-Branth P, Casadevante VF, Espenhain L, Fuursted K, Konradsen HB.
PMID: 27957553
Heliyon. 2016 Nov 29;2(11):e00198. doi: 10.1016/j.heliyon.2016.e00198. eCollection 2016 Nov.

Since 2010, Denmark has included the 13-valent pneumococcal conjugated vaccine (PCV-13) in the childhood immunization programme. However, serotype 3 remains as an important cause of invasive pneumococcal disease (IPD) in Denmark. IPD surveillance data (1999-2016) was used to calculate...

Cite
Slotved HC, Dalby T, Harboe ZB, et al. The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination. Heliyon. 2016;2(11):e00198doi: 10.1016/j.heliyon.2016.e00198.
Slotved, H. C., Dalby, T., Harboe, Z. B., Valentiner-Branth, P., Casadevante, V. F., Espenhain, L., Fuursted, K., & Konradsen, H. B. (2016). The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination. Heliyon, 2(11), e00198. https://doi.org/10.1016/j.heliyon.2016.e00198
Slotved, Hans-Christian, et al. "The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination." Heliyon vol. 2,11 (2016): e00198. doi: https://doi.org/10.1016/j.heliyon.2016.e00198
Slotved HC, Dalby T, Harboe ZB, Valentiner-Branth P, Casadevante VF, Espenhain L, Fuursted K, Konradsen HB. The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination. Heliyon. 2016 Nov 29;2(11):e00198. doi: 10.1016/j.heliyon.2016.e00198. eCollection 2016 Nov. PMID: 27957553; PMCID: PMC5133732.
Copy Download .nbib Format: NLM
Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis.

Heart (British Cardiac Society)

Pries-Heje MM, Hasselbalch RB, Wiingaard C, Fosbøl EL, Glenthøj AB, Ihlemann N, Gill SUA, Christiansen U, Elming H, Bruun NE, Povlsen JA, Helweg-Larsen J, Schultz M, Østergaard L, Fursted K, Christensen JJ, Rosenvinge F, Køber L, Tønder N, Moser C, Iversen K, Bundgaard H.
PMID: 34611042
Heart. 2021 Oct 05; doi: 10.1136/heartjnl-2021-319637. Epub 2021 Oct 05.

OBJECTIVE: To assess the prevalence and severity of anaemia in patients with left-sided infective endocarditis (IE) and association with mortality.METHODS: In the Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis trial, 400 patients with IE were randomised to conventional...

Cite
Pries-Heje MM, Hasselbalch RB, Wiingaard C, et al. Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis. Heart. 2021;doi: 10.1136/heartjnl-2021-319637.
Pries-Heje, M. M., Hasselbalch, R. B., Wiingaard, C., Fosbøl, E. L., Glenthøj, A. B., Ihlemann, N., Gill, S. U. A., Christiansen, U., Elming, H., Bruun, N. E., Povlsen, J. A., Helweg-Larsen, J., Schultz, M., Østergaard, L., Fursted, K., Christensen, J. J., Rosenvinge, F., Køber, L., Tønder, N., Moser, C., Iversen, K., & Bundgaard, H. (2021). Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis. Heart (British Cardiac Society), . https://doi.org/10.1136/heartjnl-2021-319637
Pries-Heje, Mia Marie, et al. "Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis." Heart (British Cardiac Society) vol. (2021). doi: https://doi.org/10.1136/heartjnl-2021-319637
Pries-Heje MM, Hasselbalch RB, Wiingaard C, Fosbøl EL, Glenthøj AB, Ihlemann N, Gill SUA, Christiansen U, Elming H, Bruun NE, Povlsen JA, Helweg-Larsen J, Schultz M, Østergaard L, Fursted K, Christensen JJ, Rosenvinge F, Køber L, Tønder N, Moser C, Iversen K, Bundgaard H. Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis. Heart. 2021 Oct 05; doi: 10.1136/heartjnl-2021-319637. Epub 2021 Oct 05. PMID: 34611042.
Copy Download .nbib Format: NLM
High prevalence of methicillin-resistant .

Journal of migration and health

Eiset AH, Stensvold CR, Fuursted K, Nielsen HV, Wejse C.
PMID: 34405169
J Migr Health. 2020 Dec 05;1:100016. doi: 10.1016/j.jmh.2020.100016. eCollection 2020.

INTRODUCTION: Concerns have been raised regarding the emergence of antimicrobial-resistance and parasitic infections in the European refugee population. Here, we estimated the prevalence of intestinal parasites and selected antimicrobial-resistant bacteria in newly arrived asylum seekers in Denmark.MATERIALS AND METHODS:...

Cite
Eiset AH, Stensvold CR, Fuursted K, et al. High prevalence of methicillin-resistant . J Migr Health. 2020;1:100016doi: 10.1016/j.jmh.2020.100016.
Eiset, A. H., Stensvold, C. R., Fuursted, K., Nielsen, H. V., & Wejse, C. (2020). High prevalence of methicillin-resistant . Journal of migration and health, 1100016. https://doi.org/10.1016/j.jmh.2020.100016
Eiset, Andreas Halgreen, et al. "High prevalence of methicillin-resistant ." Journal of migration and health vol. 1 (2020): 100016. doi: https://doi.org/10.1016/j.jmh.2020.100016
Eiset AH, Stensvold CR, Fuursted K, Nielsen HV, Wejse C. High prevalence of methicillin-resistant . J Migr Health. 2020 Dec 05;1:100016. doi: 10.1016/j.jmh.2020.100016. eCollection 2020. PMID: 34405169; PMCID: PMC8352168.
Copy Download .nbib Format: NLM
Complete Genome Sequences of Aerococcus christensenii CCUG 28831T, Aerococcus sanguinicola CCUG 43001T, Aerococcus urinae CCUG 36881T, Aerococcus urinaeequi CCUG 28094T, Aerococcus urinaehominis CCUG 42038 BT, and Aerococcus viridans CCUG 4311T.

Genome announcements

Carkaci D, Dargis R, Nielsen XC, Skovgaard O, Fuursted K, Christensen JJ.
PMID: 27103727
Genome Announc. 2016 Apr 21;4(2). doi: 10.1128/genomeA.00302-16.

Strains belonging to the genus Aerococcus are causative agents of human and animal infections, including urogenital infections, bacteremia/septicemia, and infective endocarditis. This study reports the first fully closed and complete genome sequences of six type strains belonging to the...

Cite
Carkaci D, Dargis R, Nielsen XC, et al. Complete Genome Sequences of Aerococcus christensenii CCUG 28831T, Aerococcus sanguinicola CCUG 43001T, Aerococcus urinae CCUG 36881T, Aerococcus urinaeequi CCUG 28094T, Aerococcus urinaehominis CCUG 42038 BT, and Aerococcus viridans CCUG 4311T. Genome Announc. 2016;4(2)doi: 10.1128/genomeA.00302-16.
Carkaci, D., Dargis, R., Nielsen, X. C., Skovgaard, O., Fuursted, K., & Christensen, J. J. (2016). Complete Genome Sequences of Aerococcus christensenii CCUG 28831T, Aerococcus sanguinicola CCUG 43001T, Aerococcus urinae CCUG 36881T, Aerococcus urinaeequi CCUG 28094T, Aerococcus urinaehominis CCUG 42038 BT, and Aerococcus viridans CCUG 4311T. Genome announcements, 4(2), . https://doi.org/10.1128/genomeA.00302-16
Carkaci, Derya, et al. "Complete Genome Sequences of Aerococcus christensenii CCUG 28831T, Aerococcus sanguinicola CCUG 43001T, Aerococcus urinae CCUG 36881T, Aerococcus urinaeequi CCUG 28094T, Aerococcus urinaehominis CCUG 42038 BT, and Aerococcus viridans CCUG 4311T." Genome announcements vol. 4,2 (2016). doi: https://doi.org/10.1128/genomeA.00302-16
Carkaci D, Dargis R, Nielsen XC, Skovgaard O, Fuursted K, Christensen JJ. Complete Genome Sequences of Aerococcus christensenii CCUG 28831T, Aerococcus sanguinicola CCUG 43001T, Aerococcus urinae CCUG 36881T, Aerococcus urinaeequi CCUG 28094T, Aerococcus urinaehominis CCUG 42038 BT, and Aerococcus viridans CCUG 4311T. Genome Announc. 2016 Apr 21;4(2). doi: 10.1128/genomeA.00302-16. PMID: 27103727; PMCID: PMC4841142.
Copy Download .nbib Format: NLM
[No title available]

Journal of oral microbiology

Stensvold CR, Nielsen M, Baraka V, Lood R, Fuursted K, Nielsen HV.
PMID: 34104347
J Oral Microbiol. 2021 May 19;13(1):1924598. doi: 10.1080/20002297.2021.1924598.

OBJECTIVE: To describe epidemiological features, genetic diversity, and associations with oral microbiome signatures of METHODS: DNAs from 92 oral washings from 52 participants were subject to metabarcoding of ribosomal genes. DNA sequences were identified to genus level and submitted...

Cite
Stensvold CR, Nielsen M, Baraka V, et al. . J Oral Microbiol. 2021;13(1):1924598doi: 10.1080/20002297.2021.1924598.
Stensvold, C. R., Nielsen, M., Baraka, V., Lood, R., Fuursted, K., & Nielsen, H. V. (2021). . Journal of oral microbiology, 13(1), 1924598. https://doi.org/10.1080/20002297.2021.1924598
Stensvold, Christen Rune, et al. "." Journal of oral microbiology vol. 13,1 (2021): 1924598. doi: https://doi.org/10.1080/20002297.2021.1924598
Stensvold CR, Nielsen M, Baraka V, Lood R, Fuursted K, Nielsen HV. . J Oral Microbiol. 2021 May 19;13(1):1924598. doi: 10.1080/20002297.2021.1924598. PMID: 34104347; PMCID: PMC8143617.
Copy Download .nbib Format: NLM
Vancomycin gene selection in the microbiome of urban Rattus norvegicus from hospital environment.

Evolution, medicine, and public health

Hansen TA, Joshi T, Larsen AR, Andersen PS, Harms K, Mollerup S, Willerslev E, Fuursted K, Nielsen LP, Hansen AJ.
PMID: 27412864
Evol Med Public Health. 2016 Aug 03;2016(1):219-26. doi: 10.1093/emph/eow021. Print 2016.

BACKGROUND AND OBJECTIVES: Widespread use of antibiotics has resulted in selection pressure on genes that make bacteria non-responsive to antibiotics. These antibiotic-resistant bacteria are currently a major threat to global health. There are various possibilities for the transfer of...

Cite
Hansen TA, Joshi T, Larsen AR, et al. Vancomycin gene selection in the microbiome of urban Rattus norvegicus from hospital environment. Evol Med Public Health. 2016;2016(1):219-26doi: 10.1093/emph/eow021.
Hansen, T. A., Joshi, T., Larsen, A. R., Andersen, P. S., Harms, K., Mollerup, S., Willerslev, E., Fuursted, K., Nielsen, L. P., & Hansen, A. J. (2016). Vancomycin gene selection in the microbiome of urban Rattus norvegicus from hospital environment. Evolution, medicine, and public health, 2016(1), 219-26. https://doi.org/10.1093/emph/eow021
Hansen, Thomas Arn, et al. "Vancomycin gene selection in the microbiome of urban Rattus norvegicus from hospital environment." Evolution, medicine, and public health vol. 2016,1 (2016): 219-26. doi: https://doi.org/10.1093/emph/eow021
Hansen TA, Joshi T, Larsen AR, Andersen PS, Harms K, Mollerup S, Willerslev E, Fuursted K, Nielsen LP, Hansen AJ. Vancomycin gene selection in the microbiome of urban Rattus norvegicus from hospital environment. Evol Med Public Health. 2016 Aug 03;2016(1):219-26. doi: 10.1093/emph/eow021. Print 2016. PMID: 27412864; PMCID: PMC4972940.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries